3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
2
Urinary Bladder Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Ovarian Neoplasms
1
Malignant Solid Neoplasm
1
Kidney Neoplasms
1
Hematopoietic and Lymphatic System Neoplasm
1
HIV Infections
1
Endometrial Neoplasms
1
Colonic Neoplasms
1
Cigarette Smoking-Related Carcinoma
1
Carcinoma, Renal Cell
1
Interventions
asciminib
7
Cyclophosphamide
6
fludarabine phosphate
5
fludarabine
4
nilotinib
3
Whole-Body Irradiation
3
Mycophenolic Acid
3
Imatinib Mesylate
3
venetoclax
2
Thiotepa
2
Tacrolimus
2
Granulocyte Colony-Stimulating Factor
2
Filgrastim
2
Dasatinib
2
Cyclosporine
2
treosulfan
1
thymoglobulin
1
selinexor
1
ponatinib
1
olverembatinib
1
midostaurin
1
merphos
1
gilteritinib
1
bosutinib
1
blinatumomab
1
aldesleukin
1
Stem Cell Transplantation
1
Peripheral Blood Stem Cell Transplantation
1
Methotrexate
1
Mesna
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
×
Health Promotion
×
30 days
×
Clear all
No trials found.